Personalized medicine: ethics for clinical trials

Area of Science:

• Medical Ethics
• Clinical Research
• Personalized Medicine

Background:

• Modern medical ethics, emphasizing respect for persons, beneficence, and justice, were established post-World War II.
• Clinical trials undergo rigorous oversight, including institutional review boards, to ensure compliance with regulations, privacy, informed consent, and safety.
• Ethical training and patient advocates are increasingly integral to clinical research settings.

Purpose of the Study:

• To introduce ethical considerations in clinical research, particularly within the context of personalized medicine.
• To provide historical context for the development of medical ethics in research.
• To outline general ethical guidelines for initiating clinical trials.

Main Methods:

• Review of historical development of medical ethical codes.
• Analysis of the heightened scrutiny and oversight in clinical trials.
• Examination of ethical implications in personalized medicine, where each patient is a unique case.
• Use of case studies to illustrate ethical dilemmas.
• Description of general ethical guidelines for trial initiation.

Main Results:

• Clinical trials are subject to extensive regulatory requirements and ethical safeguards.
• Personalized medicine introduces unique ethical challenges due to individualized treatments and inherent uncertainties.
• A shared responsibility model between patients and researchers is implied in personalized medicine.
• Historical context highlights the evolution of ethical principles in medical research.

Conclusions:

• Adherence to established ethical codes and rigorous oversight is paramount in clinical research.
• The unique nature of personalized medicine necessitates a re-evaluation of shared responsibilities and ethical considerations.
• Understanding historical context and general guidelines is essential for initiating ethical clinical trials.